Disclosure notice regarding Vitrolife in pursuance of share loan

Disclosure notice regarding Vitrolife in pursuance of share loan Skanditek has on June 15, 2001 lent 4,637,500 shares in Vitrolife AB to Enskilda Securities AB. The share loan was given in order to facilitate delivery of shares in connection with Vitrolife's new issue and listing on the Stockholm Exchange on June 26, 2001. Enskilda Securities has today redelivered 4,000,000 shares. Skanditek's holding in Vitrolife thereafter amounts to 5,858,200 shares, which corresponds to 31.9 percent of capital and votes. Remaining 637,500 shares are lent in order to facilitate delivery of shares in connection with the over-allotment option that Enskilda Securities may come to exercise. Stockholm, July 3, 2001 SKANDITEK INDUSTRIFÖRVALTNING AB (publ) For further information, please contact: Patrik Tigerschiöld, president and chief executive officer, phone +46 8 614 00 20, mobile +46 70 777 71 90, e-mail patrik.tigerschiold@skanditek.se. Håkan Dahlin, chief financial officer, phone +46 8 614 00 20, mobile +46 709 28 06 52, e-mail hakan.dahlin@skanditek.se. Skanditek is an industrial holding company owning stock in Swedish unlisted and listed companies. Our business concept is to be an active and long-term stockholder and to further the portfolio companies' development by providing industrial and financial competence at board and management level. The portfolio comprises 16 companies within electronics, information technology, biotechnology and services. The major holdings are in Axis (14%), LGP Telecom Holding (10%), Mydata Automation (39%), PartnerTech (26%), Vellinge Electronics (100%) and Vitrolife (35% incl lent shares). Skanditek is listed on the Stockholm Ex-change's O list. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2001/07/03/20040930BIT20630/wkr0001.pdf